3:55pm ET
Health and Healthcare
Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck
According to Credit Suisse, Pfizer investors might be getting to make up some of that relative underperformance of late.
Companies
Merck & Co Inc
$149.54
▼ $3.56 (−2.33%) today
Markets closed · 8:49pm ET
MRK Coverage
Page 21
8:50am ET
Health and Healthcare
Major Pharma Sees a Few Wild Swings in Short Interest
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
12:10pm ET
Investing
The 10 Companies Buying Back the Most Stock
Stock buybacks have come under more scrutiny by the public and politicians in recent years, but companies still aggressively are buying back shares of their own stock.
1:45pm ET
Investing
As Recession Fears Grow, 15 Stocks to Survive a Stock Market Correction
During times of uncertainty and fear, many investors have to look for a place to hide when they know that they have to keep having income from investments to supplement their income,…
8:35am ET
Health and Healthcare
Big Pharma Short Interest Backs Off, With One Huge Exception
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
7:30am ET
Investing
5 Safe Merrill Lynch US 1 List Stocks to Buy That Pay Big Dividends
These five outstanding ideas from Merrill Lynch are decidedly more conservative. Given their strong and consistent dividends, they offer investors excellent total return potential and a safer way to play the stock…
8:30am ET
Health and Healthcare
Major Pharma Sees Tremendous Rise in Short Interest
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
8:52am ET
Investing
Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and Zillow.
9:55am ET
Health and Healthcare
Is Merck Overpaying for Immune Design?
Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some might call a ridiculous premium
Chris Lange 8:45am ET
Investing
Top Analyst Upgrades and Downgrades: CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Air, S&P, Transocean, Walmart and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Airlines, S&P, Transocean and Walmart.
9:35am ET
Health and Healthcare
Major Pharma Scares Off Short Sellers
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
7:10am ET
Investing
The 15 Best Dividend Stocks for Retirees to Own
There are many stocks that are targeted toward mature adults and seniors or that offer classical investing themes for those who are retired now or are within a decade of retiring.
7:25am ET
Investing
Merrill Lynch Adds Top Large Cap Pharmaceutical Leader to US 1 List
A new addition to the Merrill Lynch US 1 list, plus four additional stocks that offer a fair degree of safety and solid dependable dividends. With the market volatility spiking, it makes…
8:35am ET
Health and Healthcare
Merck Clears a Low Hurdle for Q4 Earnings
Merck released better-than-expected fourth-quarter financial results after the markets closed on Thursday.
Chris Lange 11:15am ET
Health and Healthcare
What to Expect When Merck Reports on Friday
Merck is scheduled to release its fourth-quarter before the markets open on Friday, and analysts are looking for solid top and bottom line growth.
Chris Lange